The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.
Eur Heart J. 2021 Nov 7;42(42):4389-4400. doi: 10.1093/eurheartj/ehab447.
Eur Heart J. 2021.
PMID: 34343257
Free PMC article.